Benjamin E Willcox

14PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Environmental epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 03, 2026
Insights into the Mechanism of Action of Phosphoantigen Prodrugs on Vγ9Vδ2 T Cell Activation.

|Apr 04, 2025
A Brief Molecular History of Vγ9Vδ2 TCR-Mediated Phosphoantigen Sensing.

Fiyaz Mohammed, Carrie R Willcox, Benjamin E Willcox

|Jul 19, 2024
Phosphonodiamidate prodrugs of phosphoantigens (ProPAgens) exhibit potent Vγ9/Vδ2 T cell activation and eradication of cancer cells.

Qin Xu, Maria Sharif, Edward James

|Nov 22, 2023
A distinct topology of BTN3A IgV and B30.2 domains controlled by juxtamembrane regions favors optimal human γδ T cell phosphoantigen sensing.

Mohindar M Karunakaran, Hariharan Subramanian, Yiming Jin

|Jul 31, 2021
Human γδ T cell sensing of AMPK-dependent metabolic tumor reprogramming through TCR recognition of EphA2.

Christelle Harly, Stephen Paul Joyce, Charlotte Domblides

|Apr 26, 2021
Generation of Stable Isopentenyl Monophosphate Aryloxy Triester Phosphoramidates as Activators of Vγ9Vδ2 T Cells.

Qin Xu, Taher E Taher, Elizabeth Ashby

Pageof 3

Frequent Collaborators

6 joint publications

Youcef Mehellou

5 joint publications

Carrie R Willcox

3 joint publications

Martin S Davey

2 joint publications

Fiyaz Mohammed